BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24212499)

  • 1. Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis.
    Lyman GH; Eckert L; Wang Y; Wang H; Cohen A
    Oncologist; 2013; 18(12):1321-9. PubMed ID: 24212499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
    Khorana AA; Dalal M; Lin J; Connolly GC
    Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
    Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
    J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-cause and disease-related health care costs associated with recurrent venous thromboembolism.
    Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Hossou Y; Schein J; Kaatz S
    Thromb Haemost; 2013 Dec; 110(6):1288-97. PubMed ID: 24085327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.
    Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ
    Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry.
    Ohashi Y; Ikeda M; Kunitoh H; Sasako M; Okusaka T; Mukai H; Fujiwara K; Nakamura M; Oba MS; Kimura T; Ibusuki K; Takita A; Sakon M
    Thromb Res; 2022 May; 213():203-213. PubMed ID: 35282898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
    Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
    Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study.
    Huang H; Korn JR; Mallick R; Friedman M; Nichols C; Menzin J
    J Thromb Thrombolysis; 2012 Nov; 34(4):446-56. PubMed ID: 22581282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer.
    Connolly GC; Dalal M; Lin J; Khorana AA
    Lung Cancer; 2012 Dec; 78(3):253-8. PubMed ID: 23026639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery.
    Baser O; Supina D; Sengupta N; Wang L; Kwong L
    Am J Health Syst Pharm; 2010 Sep; 67(17):1438-45. PubMed ID: 20720243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and predictors of chemotherapy-associated venous thromboembolism: the prospective PREVENT study.
    Kakkos SK; Arnaoutoglou E; Tsolakis IA; Giannoukas A; Papadimitriou CA; Kentepozidis N; Boukovinas I; Kalofonos HP; Labropoulos N; Matsagkas M
    Int Angiol; 2020 Apr; 39(2):112-117. PubMed ID: 32057213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Societal costs of venous thromboembolism and subsequent major bleeding events: a national register-based study.
    Gustafsson N; Poulsen PB; Stallknecht SE; Dybro L; Paaske Johnsen S
    Eur Heart J Qual Care Clin Outcomes; 2020 Apr; 6(2):130-137. PubMed ID: 31287536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
    Kuderer NM; Culakova E; Lyman GH; Francis C; Falanga A; Khorana AA
    Oncologist; 2016 Jul; 21(7):861-7. PubMed ID: 27125754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of venous thromboembolism occurrence in medical patients among the insured population.
    Spyropoulos AC; Hussein M; Lin J; Battleman D
    Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants.
    Streiff M; Milentijevic D; McCrae KR; Laliberté F; Lejeune D; Lefebvre P; Schein J; Khorana AA
    J Med Econ; 2019 Nov; 22(11):1134-1140. PubMed ID: 31106638
    [No Abstract]   [Full Text] [Related]  

  • 16. Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study.
    Howlett J; Benzenine E; Cottenet J; Foucher P; Fagnoni P; Quantin C
    BMC Cancer; 2020 May; 20(1):461. PubMed ID: 32448219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty.
    Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
    J Med Econ; 2012; 15(4):644-53. PubMed ID: 22356512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Ferrante N; De Tursi M; Iacobelli S; Cuccurullo F; Büller HR; Feragalli B; Porreca E
    Thromb Haemost; 2010 Nov; 104(5):1049-54. PubMed ID: 20806119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
    Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
    Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated With Different Outcomes Among Patients With Venous Thromboembolism?
    Spyropoulos AC; Preblick R; Kwong WJ; Lingohr-Smith M; Lin J
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):532-541. PubMed ID: 27899520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.